Skin cancer linked to future risk of other cancers

White people who have types of skin cancer other than melanoma may be at increased risk of having other forms of cancer in the future, according to a new study.

Lambrolizumab given Breakthrough Therapy designation for advanced melanoma

The FDA has designated Merck's lambrolizumab (MK-3475) as Breakthrough Therapy for the treatment of patients with advanced melanoma. Lambrolizumab is an investigational antibody therapy targeting Programmed Death receptor.

CT data help predict survival in metastatic melanoma

Computerized tomography adds to lactate dehydrogenase (LDH) levels in predicting survival among persons with metastatic melanoma on bevacizumab.

Pediatric melanomas increasing by 2% each year

The incidence of pediatric melanoma has increased by about 2% per year, and this incidence trend is influenced by gender, age, and stage at diagnosis, primary site, and UV-B exposure.

Aspirin may lower some women's risk of melanoma

Women who take aspirin have a reduced risk of developing melanoma, according to a new observational study. Further, the longer they take it, the lower the risk declines.

Melanoma uses weak immune cells to its advantage

Melanoma tumors create conditions that attract immunoglobulin G4 (IgG4), the B-cell antibody class least effective in activating immune response.

First evidence that obesity gene is a risk factor for melanoma is found

People with particular variations in a stretch of DNA within the FTO gene, called intron 8, could be at greater risk of developing melanoma.

Aspirin reduces melanoma risk in postmenopausal Caucasian women

For postmenopausal Caucasian women, aspirin use is associated with a significantly reduced risk of melanoma.

Clinical Trial: Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma

Clinical Trial: Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells

Clinical Trial: Characterisation of T Lymphocytes, NK Cells and Macrophages in Melanoma Patients